Jinling Pharmaceutical News

Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the progress of the acquisition of part of the shares of the Xingong Fund and the non-cash distribution of shares in the Xingong Fund and related transactions

Nov 18 11:00 ET

Jinling Pharmaceutical: 2024-093 Announcement of Jinling Pharmaceutical Co., Ltd. on the completion of the cancellation of some restricted stock repurchases

Nov 17 11:00 ET

Jinling Pharmaceutical: Legal Opinion on the Implementation of Jinling Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan to Repurchase and Cancel Some Restricted Shares

Nov 17 11:00 ET

Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on issuing some restricted shares to specific targets and releasing restricted listing and circulation

Oct 27 12:00 ET

Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on Jinling Pharmaceutical Co., Ltd.\'s acquisition of part of the Nanjing Xingong Medical Industry Investment Fund Partnership (Limited Partnership) fund shares and related transactions

Oct 21 12:00 ET

Jinling Pharmaceutical: Verification Opinions of CITIC Securities Co., Ltd. on Jinling Pharmaceutical Co., Ltd.\'s acquisition of part of the shares of Xingong Fund and the non-cash distribution of shares in Xingong Fund and related transactions

Oct 21 12:00 ET

Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the acquisition of part of the shares of the Xingong Fund and the non-cash distribution of shares in the Xingong Fund and related transactions

Oct 21 12:00 ET

Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on adjusting the repurchase price of the 2021 Restricted Stock Incentive Plan and the repurchase and cancellation of some restricted stocks that have been granted but the sales restrictions have not yet been lifted

Aug 26 12:00 ET

Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on Jinling Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Repurchase Price Adjustment and Repurchase Cancellation of Some Restricted Shares

Aug 26 12:00 ET

Jinling Pharmaceutical: Jinling Pharmaceutical Co., Ltd. 2023 Equity Distribution Implementation Notice

May 23 12:00 ET

Jinling Pharmaceutical: CITIC Securities Co., Ltd. listing sponsorship for Jinling Pharmaceutical Co., Ltd. to issue A-shares to specific targets in 2023

Apr 18 12:00 ET

Jinling Pharmaceutical: Announcement on the issuance of A-shares by Jinling Pharmaceutical Co., Ltd. to specific targets in 2023

Apr 18 12:00 ET

Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on passively diluting the shareholders' shareholding ratio by more than 1%

Apr 18 12:00 ET

Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on the disclosure of stock listing notices issued to specific targets

Apr 18 12:00 ET

Jinling Pharmaceutical: Capital Verification Report on the Issuance of A-shares by Jinling Pharmaceutical Co., Ltd. to specific targets to raise capital

Mar 28 12:00 ET

Jinling Pharmaceutical: Report on the issuance of A-shares to specific targets by Jinling Pharmaceutical Co., Ltd. in 2023

Mar 28 12:00 ET

Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on the disclosure of a report on the issuance of shares to specific targets

Mar 28 12:00 ET

Jinling Pharmaceutical: Report of CITIC Securities Co., Ltd. on the issuance process of Jinling Pharmaceutical Co., Ltd.'s issuance process of A-shares to specific targets in 2023 and compliance with subscription targets

Mar 28 12:00 ET

Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the issuance process of Jinling Pharmaceutical Co., Ltd. to issue A shares to specific targets in 2023 and compliance with subscription targets

Mar 28 12:00 ET

Jinling Pharmaceutical: CITIC Securities Co., Ltd.'s inspection opinions on extending the validity period of the resolution of Jinling Pharmaceutical Co., Ltd.'s shareholders' meeting in 2023 to issue A shares to specific targets and the validity period of

Mar 12 12:00 ET